These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1212 related articles for article (PubMed ID: 12549803)

  • 1. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
    Cherif A; Jabnoun S; Khrouf N
    Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
    Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
    N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic closure of the ductus arteriosus: benefits and limitations.
    Mercanti I; Boubred F; Simeoni U
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation for the use of oral ibuprofen and intravenous indomethacin in Korean infants with patent ductus.
    Heo MJ; Lee OS; Lim SC
    Arch Pharm Res; 2012 Sep; 35(9):1673-83. PubMed ID: 23054725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of ibuprofen in neonates in the treatment of patent ductus arteriosus.
    Van Overmeire B
    Int J Clin Pract Suppl; 2003 Apr; (135):23-7. PubMed ID: 12723743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome.
    Van Overmeire B; Van de Broek H; Van Laer P; Weyler J; Vanhaesebrouck P
    J Pediatr; 2001 Feb; 138(2):205-11. PubMed ID: 11174617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibuprofen lysine for the prevention and treatment of patent ductus arteriosus.
    Pai VB; Sakadjian A; Puthoff TD
    Pharmacotherapy; 2008 Sep; 28(9):1162-82. PubMed ID: 18752387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants].
    Adamska E; Helwich E; Rutkowska M; Zacharska E; Piotrowska A
    Med Wieku Rozwoj; 2005; 9(3 Pt 1):335-54. PubMed ID: 16547381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams.
    Supapannachart S; Khowsathit P; Patchakapati B
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S87-92. PubMed ID: 10730525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
    Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
    Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus.
    Fanos V; Benini D; Verlato G; Errico G; Cuzzolin L
    Fundam Clin Pharmacol; 2005 Apr; 19(2):187-93. PubMed ID: 15810899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibuprofen: alternative treatment for patent ductus arteriosus.
    Flores M
    Neonatal Netw; 2003; 22(2):27-31. PubMed ID: 12696723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus.
    Leonhardt A; Strehl R; Barth H; Seyberth HW
    Acta Paediatr; 2004 Feb; 93(2):233-40. PubMed ID: 15046280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants.
    Richards J; Johnson A; Fox G; Campbell M
    Pediatrics; 2009 Aug; 124(2):e287-93. PubMed ID: 19651568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study.
    Heyman E; Morag I; Batash D; Keidar R; Baram S; Berkovitch M
    Pediatrics; 2003 Nov; 112(5):e354. PubMed ID: 14595076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral ibuprofen prophylaxis for symptomatic patent ductus arteriosus of prematurity.
    Sangtawesin V; Sangtawesin C; Raksasinborisut C; Sathirakul K; Kanjanapattanakul W; Khorana M; Horpaopan S
    J Med Assoc Thai; 2006 Mar; 89(3):314-21. PubMed ID: 16696414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.